A detailed history of Pdt Partners, LLC transactions in Nevro Corp stock. As of the latest transaction made, Pdt Partners, LLC holds 12,975 shares of NVRO stock, worth $109,249. This represents 0.02% of its overall portfolio holdings.

Number of Shares
12,975
Holding current value
$109,249
% of portfolio
0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$13.56 - $20.78 $175,941 - $269,620
12,975 New
12,975 $187,000
Q2 2023

Aug 14, 2023

SELL
$22.62 - $39.32 $75,347 - $130,974
-3,331 Reduced 18.52%
14,659 $372,000
Q1 2023

May 15, 2023

SELL
$30.17 - $41.11 $1.14 Million - $1.55 Million
-37,725 Reduced 67.71%
17,990 $650,000
Q4 2022

Feb 14, 2023

BUY
$36.43 - $49.4 $827,981 - $1.12 Million
22,728 Added 68.9%
55,715 $2.21 Million
Q3 2022

Nov 14, 2022

SELL
$40.66 - $53.03 $197,404 - $257,460
-4,855 Reduced 12.83%
32,987 $1.54 Million
Q2 2022

Aug 15, 2022

BUY
$40.85 - $77.67 $1.4 Million - $2.66 Million
34,251 Added 953.8%
37,842 $1.66 Million
Q1 2022

May 16, 2022

BUY
$59.95 - $92.06 $215,280 - $330,587
3,591 New
3,591 $260,000
Q1 2021

May 17, 2021

SELL
$132.81 - $182.18 $846,663 - $1.16 Million
-6,375 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$138.17 - $184.34 $880,833 - $1.18 Million
6,375 New
6,375 $1.1 Million
Q2 2019

Aug 14, 2019

SELL
$58.04 - $66.99 $3.52 Million - $4.07 Million
-60,729 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$35.52 - $62.62 $937,124 - $1.65 Million
-26,383 Reduced 30.29%
60,729 $3.8 Million
Q4 2018

Feb 14, 2019

BUY
$35.43 - $56.29 $1.34 Million - $2.12 Million
37,710 Added 76.33%
87,112 $3.39 Million
Q3 2018

Nov 14, 2018

SELL
$44.22 - $75.47 $136,993 - $233,806
-3,098 Reduced 5.9%
49,402 $2.82 Million
Q2 2018

Aug 14, 2018

BUY
$72.38 - $92.5 $3.8 Million - $4.86 Million
52,500 New
52,500 $4.19 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $298M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Pdt Partners, LLC Portfolio

Follow Pdt Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.